Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase 2 Trial

Helliwell, Phillip S; Deodhar, Atul; Gottlieb, Alice B; Boehncke, Wolf-Henning; Xu, Xie L; Xu, Stephen; Wang, Yuhua; Hsia, Elizabeth C; Gladman, Dafna D; Ritchlin, Christopher T

doi:10.1002/acr.24046

Scientific article

English

Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase 2 Trial

ContributorsHelliwell, Phillip S; Deodhar, Atul; Gottlieb, Alice B; Boehncke, Wolf-Henning; Xu, Xie L; Xu, Stephen; Wang, Yuhua; Hsia, Elizabeth C; Gladman, Dafna D; Ritchlin, Christopher T

Published inArthritis Care and Research

Publication date2019

Abstract

Objective: Assess performance of psoriatic arthritis (PsA) composite indices and evaluate guselkumab's effect on achieving low disease activity or remission.

Affiliation entities

Research groups

Inflammation cutanée (919)

Citation (ISO format)

HELLIWELL, Phillip S et al. Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase 2 Trial. In: Arthritis Care and Research, 2019. doi: 10.1002/acr.24046

Article (Accepted version)

OA OTHER

Identifiers

PID : unige:138257
DOI : 10.1002/acr.24046
PMID : 31421033

Additional URL for this publicationhttps://onlinelibrary.wiley.com/doi/abs/10.1002/acr.24046

Journal ISSN2151-464X

312views

198downloads

Creation19/06/2020 13:06:00

First validation19/06/2020 13:06:00

Update24/01/2025 15:56:35

Status update24/01/2025 15:56:35

Last indexation24/01/2025 16:04:42

Archive ouverte UNIGE

Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase 2 Trial

Objective: Assess performance of psoriatic arthritis (PsA) composite indices and evaluate guselkumab's effect on achieving low disease activity or remission.

Technical informations